glp-1 for autoimmune inflammation drugs calm beyond diabetes and weight loss Frontiers | GLP-1 receptor agonist

MIM received honoraria for speaking at meetings from AstraZeneca, Novo Nordisk, Bruno Farmaceutici, Mundipharma, and Sanofi

1 Introduction The success and ever increasing interest in incretin-based therapies and drugs especially sitagliptin, vildagliptin and exenatide depict their immense importance in improving patient outcomes in T2DM (Nasr and Sadek, 2022)

Here are some other things to keep in mind when taking CONTRAVE: If youre experiencing any unwanted side effects of your medication, dont hesitate to reach out to your healthcare provider or pharmacistthey can give you personalized guidance

Although the cardioprotective effects of GLP-1RA are more established in atherosclerotic cardiovascular disease than in heart failure, recent studies demonstrate a modest but clinically meaningful benefit in heart failure with preserved ejection fraction (HFpEF), particularly among obese patients

Athyros V, Tziomalos K, Katsiki N, Gossios T, et al

Probiotics and prebiotics have generated interest due to their effects on gut microbiota composition